Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hazem Elewa & Ahmed Awaisu. (2019) Pharmacogenomics In Pharmacy Practice: Current Perspectives. Integrated Pharmacy Research and Practice 8, pages 97-104.
Read now
Read now
Weiran Dai, Ziliang Ye, Lang Li & Qiang Su. (2018) Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Drug Design, Development and Therapy 12, pages 2039-2049.
Read now
Read now
André J Scheen. (2011) Cytochrome P450-mediated cardiovascular drug interactions. Expert Opinion on Drug Metabolism & Toxicology 7:9, pages 1065-1082.
Read now
Read now
Articles from other publishers (35)
ShaoJun Zheng, YiFan Xu, Qiong Jie, HuiWen Mu, Xing Zhang, JianCheng Zhu, YuBing Zhu, XiJing Chen & ShaoLiang Chen. (2023) A systematic study to evaluate the safety of ticagrelor combined with aspirin in the treatment of PCI patients in Chinese population: A single nucleotide polymorphisms study. Drug Metabolism and Pharmacokinetics 53, pages 100468.
Crossref
Crossref
Alice Ma, Harshil Dharamdasani Detaram, Brendan Steinfort, Tim Harrington, Thanh N. Nguyen, Mohamad Abdalkader, George Siopis, Philip M. Bath, Permesh Singh Dhillon, Anna Podlasek, Adnan I. Qureshi, Zhongming Qiu & Kailash Krishnan. (2023) Antiplatelet Therapy in Neurointervention. Seminars in Neurology 43:03, pages 466-479.
Crossref
Crossref
Marcel Hrubša, Lukáš Konečný, Markéta Paclíková, Mst Shamima Parvin, Pavel Skořepa, František Musil, Jana Karlíčková, Lenka Javorská, Kateřina Matoušová, Lenka Kujovská Krčmová, Alejandro Carazo, Alena Šmahelová, Vladimír Blaha & Přemysl Mladěnka. (2022) The Antiplatelet Effect of 4-Methylcatechol in a Real Population Sample and Determination of the Mechanism of Action. Nutrients 14:22, pages 4798.
Crossref
Crossref
Katelyn Marsden, Hannah Y. Mak, C. Patrick Crooks, Preethy Pankaj, Thuhien Nguyen & David Tirschwell. (2021) A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke. Current Cardiology Reports 23:10.
Crossref
Crossref
Adel Alhazzani, Poongothai Venkatachalapathy, Sruthi Padhilahouse, Mohan Sellappan, Murali Munisamy, Mangaiyarkarasi Sekaran & Amit Kumar. (2021) Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review. Frontiers in Neurology 12.
Crossref
Crossref
Benjamin A. Rodwin, Di Lu, Antonio Giaimo, Amarnath Annapureddy, Ramesh Daggubati, Jeptha Curtis, Christopher T. Sciria, Tracy Y. Wang & Nihar R. Desai. (2020) Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain–MI Registry. International Journal of Cardiology 304, pages 14-20.
Crossref
Crossref
Michaël Hardy, Camie Dupuis, Anne-Sophie Dincq, Hugues Jacqmin, Thomas Lecompte, François Mullier & Sarah Lessire. (2020) Reduction of Preoperative Waiting Time Before Urgent Surgery for Patients on P2Y12 Inhibitors Using Multiple Electrode Aggregometry: A Retrospective Study. Journal of Clinical Medicine 9:2, pages 424.
Crossref
Crossref
Neetu Soni, Namrata Soni, Rahul Maheshwari, Shreya Thakkar, Dilip Sharma, Rakesh K. Tekade, Nagaraja Sreeharsha & Muktika Tekade. 2020. The Future of Pharmaceutical Product Development and Research. The Future of Pharmaceutical Product Development and Research
413
446
.
Berat Uğuz, Selma Ari, Sencer Çamci & Hasan Ari. (2019) In vitro analysis of the effect of contrast agents on the antiaggregant effects of P2Y12 inhibitors. Thrombosis Research 183, pages 91-97.
Crossref
Crossref
Athanasios Karathanos, Yingfeng Lin, Lisa Dannenberg, Claudio Parco, Volker Schulze, Maximilian Brockmeyer, Christian Jung, Yvonne Heinen, Stefan Perings, Uwe Zeymer, Malte Kelm, Amin Polzin & Georg Wolff. (2019) Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis. Canadian Journal of Cardiology 35:11, pages 1576-1588.
Crossref
Crossref
Phillip A. Bonney, Benjamin Yim, Waleed Brinjikji & Brian P. Walcott. (2019) Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice. Molecular Case Studies 5:2, pages a003731.
Crossref
Crossref
Jeremy Robbins & Eli V. Gelfand. 2019. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting
233
259
.
Jingjing Peng, Lifen Zhao, Lanlan Wang, Hui Chen, Yunguang Qiu, Jiang Wang, Huaiyu Yang, Jun Liu & Hong Liu. (2018) Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y1 receptor antagonists. European Journal of Medicinal Chemistry 158, pages 302-310.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
284
320
.
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
194
236
.
Taylor C. Bazemore, Michael G. Nanna & Sunil V. Rao. (2017) Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina. Journal of Thrombosis and Thrombolysis 44:3, pages 303-315.
Crossref
Crossref
Bridget Paravattil & Hazem Elewa. (2016) Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome. Journal of Cardiovascular Pharmacology and Therapeutics 22:4, pages 347-355.
Crossref
Crossref
Yue Zhang, János Peti-Peterdi, Anna U. Brandes, Anne Riquier-Brison, Noel G. Carlson, Christa E. Müller, Carolyn M. Ecelbarger & Bellamkonda K. Kishore. (2017) Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice. Purinergic Signalling 13:2, pages 239-248.
Crossref
Crossref
Shuaibing Liu, Xiangfen Shi, Xin Tian, Xiaojian Zhang, Zhiyong Sun & Liyan Miao. (2017) Effect of CYP3A4∗1G and CYP3A5∗3 Polymorphisms on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects. Frontiers in Pharmacology 8.
Crossref
Crossref
R. S. Foti & D. K. Dalvie. (2016) Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics. Drug Metabolism and Disposition 44:8, pages 1229-1245.
Crossref
Crossref
O. De Backer, H. Ratcovich, L. Biasco, F. Pedersen, S. Helqvist, K. Saunamäki, H.-H. Tilsted, P. Clemmensen, G. Olivecrona, H. Kelbaek, E. Jørgensen, T. Engstrøm & L. Holmvang. (2015) Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study. Thrombosis and Haemostasis 114:3, pages 623-631.
Crossref
Crossref
Paul P. Dobesh & Julie H. Oestreich. (2014) Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:10, pages 1077-1090.
Crossref
Crossref
Jennifer X. Qiao, Tammy C. Wang, Sheldon Hiebert, Carol H. Hu, William A. Schumacher, Steven A. Spronk, Charles G. Clark, Ying Han, Ji Hua, Laura A. Price, Hong Shen, Silvi A. Chacko, Gerry Everlof, Jeffrey S. Bostwick, Thomas E. Steinbacher, Yi-Xin Li, Christine S. Huang, Dietmar A. Seiffert, Robert Rehfuss, Ruth R. Wexler & Patrick Y. S. Lam. (2014)
4-Benzothiazole-7-hydroxyindolinyl Diaryl Ureas Are Potent P2Y
1
Antagonists with Favorable Pharmacokinetics: Low Clearance and Small Volume of Distribution
. ChemMedChem 9:10, pages 2327-2343.
Crossref
Crossref
Frauke Swieringa, Marijke J.E. Kuijpers, Johan W.M. Heemskerk & Paola E.J. van der Meijden. (2014) Targeting platelet receptor function in thrombus formation: The risk of bleeding. Blood Reviews 28:1, pages 9-21.
Crossref
Crossref
Jennifer X. Qiao, Tammy C. Wang, Réjean Ruel, Carl Thibeault, Alexandre L’Heureux, William A. Schumacher, Steven A. Spronk, Sheldon Hiebert, Gilles Bouthillier, John Lloyd, Zulan Pi, Dora M. Schnur, Lynn M. Abell, Ji Hua, Laura A. Price, Eddie Liu, Qimin Wu, Thomas E. Steinbacher, Jeffrey S. Bostwick, Ming Chang, Joanna Zheng, Qi Gao, Baoqing Ma, Patricia A. McDonnell, Christine S. Huang, Robert Rehfuss, Ruth R. Wexler & Patrick Y. S. Lam. (2013)
Conformationally Constrained
ortho-
Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y
1
Antagonist
. Journal of Medicinal Chemistry 56:22, pages 9275-9295.
Crossref
Crossref
Dimitrios Alexopoulos, Vassilios Gkizas, Sotirios Patsilinakos, Ioanna Xanthopoulou, Christos Angelidis, Prodromos Anthopoulos, George Makris, Angelos Perperis, Stavros Karanikas, Nikolaos Koutsogiannis, Periklis Davlouros, Spyridon Deftereos, John Chiladakis & George Hahalis. (2013) Double Versus Standard Loading Dose of Ticagrelor. Journal of the American College of Cardiology 62:10, pages 940-941.
Crossref
Crossref
Zulan Pi, James Sutton, John Lloyd, Ji Hua, Laura Price, Qimin Wu, Ming Chang, Joanna Zheng, Robert Rehfuss, Christine S. Huang, Ruth R. Wexler & Patrick Y.S. Lam. (2013) 2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents. Bioorganic & Medicinal Chemistry Letters 23:14, pages 4206-4209.
Crossref
Crossref
Réjean Ruel, Alexandre L’Heureux, Carl Thibeault, Jean-Paul Daris, Alain Martel, Laura A. Price, Qimin Wu, Ji Hua, Ruth R. Wexler, Robert Rehfuss & Patrick Y.S. Lam. (2013) New azole antagonists with high affinity for the P2Y1 receptor. Bioorganic & Medicinal Chemistry Letters 23:12, pages 3519-3522.
Crossref
Crossref
Tammy C. Wang, Jennifer X. Qiao, Charles G. Clark, Ji Jua, Laura A. Price, Qimin Wu, Ming Chang, Joanna Zheng, Christine S. Huang, Gerry Everlof, William A. Schumacher, Pancras C. Wong, Dietmar A. Seiffert, Anne B. Stewart, Jeffrey S. Bostwick, Earl J. Crain, Carol A. Watson, Robert Rehfuss, Ruth R. Wexler & Patrick Y.S. Lam. (2013) Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3239-3243.
Crossref
Crossref
Nilusha Gukathasan & Roxana Mehran. (2013) Acute Coronary Syndromes: Advances in Antithrombotics. Current Atherosclerosis Reports 15:4.
Crossref
Crossref
Mike Makris, Joost J. Van Veen, Campbell R. Tait, Andrew D. Mumford & Mike Laffan. (2012) Guideline on the management of bleeding in patients on antithrombotic agents. British Journal of Haematology 160:1, pages 35-46.
Crossref
Crossref
Dimitrios AlexopoulosIoanna XanthopoulouVassilios GkizasGeorge KassimisKonstantinos C. TheodoropoulosGeorge MakrisNikolaos KoutsogiannisAnastasia DamelouGrigorios TsigkasPeriklis DavlourosGeorge Hahalis. (2012) Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions 5:6, pages 797-804.
Crossref
Crossref
James E. Tcheng & Steven M. Mackay. (2012) Prasugrel versus Clopidogrel Antiplatelet Therapy after Acute Coronary Syndrome. American Journal Cardiovascular Drugs 12:2, pages 83-91.
Crossref
Crossref
Michael Camilleri. (2012) The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nature Reviews Gastroenterology & Hepatology 9:3, pages 173-184.
Crossref
Crossref
Kathleen A. Packard, Jennifer A. Campbell, Jon T. Knezevich & Estella M. Davis. (2012) Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:3, pages 244-273.
Crossref
Crossref